ArticlePLOS global public health2026
Changes in the prevalence, causes of visual impairment, and cataract service coverage in Karamoja, Uganda, between 2015 and 2023: Findings from two cross-sectional surveys.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Two rapid assessments of avoidable blindness (RAAB) surveys were conducted in the Karamoja subregion, Uganda, in 2015 and 2023. This paper reports the observed changes in prevalence, causes of visual impairment and coverage of cataract services and examines how the trends differ for males and females. Standard RAAB methodology was used in both studies. Two-stage cluster sampling was used to generate random samples of adults aged over 50 years. Participants underwent a simplified visual acuity (VA) exam, a lens exam, and a posterior segment exam using a direct ophthalmoscope for all participants with presenting VA < 6/18. Data was analyzed using an inbuilt command prtesti, and the regression models were developed using Stata v15 statistical software. In 2015, 3,833 participants were enrolled, and 96.8% (3,727) examined. In 2023, 3,450 were enrolled and 91.6% (3,159) examined. The prevalence of all-cause blindness was 6.0% in 2015 and 4.9% in 2023 (p-value = 0.05). The Cataract Surgical Coverage (CSC) for persons with visual acuity threshold of <3/60, < 6/60, and <6/18 was 41.6%, 34.2% and 20.5% in 2015 and 71.6%, 56.6% and 41.5% respectively, in 2023. The effective Cataract Surgical Coverage (eCSC) for the same vision category was 20.0%, 16.2%, and 9.2% in 2015 and 22.5%, 17.1% and 12.4% in 2023 The eCSC was consistently lower among females than males with the gap widening over the years: 15.9%, 12.1%, and 9.1% in females vs 28.4%, 21.6%, and 15.7% in males respectively. The CSC levels differed across assessments while eCSC values remained low. Targeted interventions are needed to improve post-surgical visual outcomes and ensure equity in access for women and individuals with moderate visual impairment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.